Selected article for: "ADMINISTERED daily and capromorelin safety"
Title: 2015 ACVIM Forum Research Abstract Program
  • Document date: 2015_5_27
    • ID: 3pnuj5ru_680
    Snippet: SAFETY OF THE GHRELIN AGONIST, CAPROMORELIN, ADMINISTERED DAILY TO BEAGLE DOGS FOR 1 YEAR. Bill Zollers 1 , Linda Rhodes 1 , Lesley Rausch-Derra 1 , Glenda Armintrout 1 , Margie Bell 2 . 1 Aratana Therapeutics, Inc., Kansas City, KS, USA, 2 Clindata Services, Fort Collins, CO, USA Capromorelin, a ghrelin agonist, is under development for use in dogs for appetite stimulation. Capromorelin, dosed orally, has been shown to stimulate food intake, wei.....
    Document: SAFETY OF THE GHRELIN AGONIST, CAPROMORELIN, ADMINISTERED DAILY TO BEAGLE DOGS FOR 1 YEAR. Bill Zollers 1 , Linda Rhodes 1 , Lesley Rausch-Derra 1 , Glenda Armintrout 1 , Margie Bell 2 . 1 Aratana Therapeutics, Inc., Kansas City, KS, USA, 2 Clindata Services, Fort Collins, CO, USA Capromorelin, a ghrelin agonist, is under development for use in dogs for appetite stimulation. Capromorelin, dosed orally, has been shown to stimulate food intake, weight gain, increases in serum growth hormone (GH) and insulin-like growth factor-1 (IGF-1) in laboratory dogs (Zollers et al. 2014) and to increase owner appetite assessment scores and body weight in a clinical field study of dogs with inappetence (Zollers and Rhodes, 2014).

    Search related documents:
    Co phrase search for related documents
    • assessment score and body weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • assessment score and clinical field: 1
    • assessment score and serum growth: 1, 2, 3
    • body weight and clinical field: 1, 2
    • body weight and food intake: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • body weight and ghrelin agonist: 1, 2
    • body weight and orally dose: 1, 2, 3
    • body weight and serum growth: 1, 2
    • body weight and weight gain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • CAPROMORELIN GHRELIN AGONIST safety and ghrelin agonist: 1
    • CAPROMORELIN GHRELIN AGONIST safety and weight gain: 1
    • clinical field and weight gain: 1, 2
    • food intake and ghrelin agonist: 1
    • food intake and serum growth: 1
    • food intake and weight gain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ghrelin agonist and weight gain: 1, 2, 3
    • serum growth and weight gain: 1, 2, 3, 4